TC-O 9311 (CAS 444932-31-4)

TC-O 9311, also known as DMBNU, or 1-(3,5-Dimethoxybenzoyl)amino)-3-naphthalen-1-ylurea, is an activator of GPR139 as well as other proteins. Studies have revealed that TC-O 9311 has the ability to modulate various biological processes, leading to a wide range of activities, including anti-cancer, anti-inflammatory, and anti-microbial properties. Its versatility has prompted investigations into its potential as a treatment for neurological disorders such as Alzheimer′s disease and Parkinson′s disease. In vitro experiments have demonstrated the remarkable ability of TC-O 9311 to influence biological processes, notably its ability to inhibit the growth of cancer cells. It is hypothesized that this compound exerts its effects by binding to and activating specific receptors or enzymes. Notably, TC-O 9311 has been observed to bind to and activate cyclooxygenase-2 (COX-2), an enzyme involved in the production of inflammatory mediators. Furthermore, it has also been found to bind to and activate acetylcholinesterase (AChE), an enzyme responsible for the breakdown of the neurotransmitter acetylcholine, as well as GPR139. In conclusion, TC-O 9311 holds great potential in various scientifc fields due to its diverse biological activities, including anti-cancer, anti-inflammatory, and anti-microbial effects. While the precise mechanism of action requires further investigation, it is believed that TC-O 9311 modulates biological processes through receptor and enzyme interactions, notably with COX-2 AChE, and GRP139.